Literature DB >> 16240471

Erlotinib in lung cancer.

William Pao, Marc Ladanyi, Vincent A Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16240471

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Multivalent Forms of the Notch Ligand DLL-1 Enhance Antitumor T-cell Immunity in Lung Cancer and Improve Efficacy of EGFR-Targeted Therapy.

Authors:  Asel K Biktasova; Duafalia F Dudimah; Roman V Uzhachenko; Kyungho Park; Anwari Akhter; Rajeswara R Arasada; Jason V Evans; Sergey V Novitskiy; Elena E Tchekneva; David P Carbone; Anil Shanker; Mikhail M Dikov
Journal:  Cancer Res       Date:  2015-09-24       Impact factor: 12.701

2.  Compound EGFR mutations and response to EGFR tyrosine kinase inhibitors.

Authors:  Susumu Kobayashi; Hannah M Canepa; Alexandra S Bailey; Sohei Nakayama; Norihiro Yamaguchi; Michael A Goldstein; Mark S Huberman; Daniel B Costa
Journal:  J Thorac Oncol       Date:  2013-01       Impact factor: 15.609

Review 3.  Targeting mitogen-activated protein kinase kinase (MEK) in solid tumors.

Authors:  Austin Duffy; Shivaani Kummar
Journal:  Target Oncol       Date:  2009-11-10       Impact factor: 4.493

4.  Pharmacokinetic and pharmacodynamic analysis of 5-aza-2'-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy.

Authors:  Metin Karahoca; Richard L Momparler
Journal:  Clin Epigenetics       Date:  2013-02-01       Impact factor: 6.551

5.  Screening for EGFR and KRAS mutations in endobronchial ultrasound derived transbronchial needle aspirates in non-small cell lung cancer using COLD-PCR.

Authors:  George Santis; Roger Angell; Guillermina Nickless; Alison Quinn; Amanda Herbert; Paul Cane; James Spicer; Ronan Breen; Emma McLean; Khalid Tobal
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

6.  Limited copy number-high resolution melting (LCN-HRM) enables the detection and identification by sequencing of low level mutations in cancer biopsies.

Authors:  Hongdo Do; Alexander Dobrovic
Journal:  Mol Cancer       Date:  2009-10-08       Impact factor: 27.401

7.  Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.

Authors:  Eliezer M Van Allen; Nikhil Wagle; Petar Stojanov; Danielle L Perrin; Kristian Cibulskis; Sara Marlow; Judit Jane-Valbuena; Dennis C Friedrich; Gregory Kryukov; Scott L Carter; Aaron McKenna; Andrey Sivachenko; Mara Rosenberg; Adam Kiezun; Douglas Voet; Michael Lawrence; Lee T Lichtenstein; Jeff G Gentry; Franklin W Huang; Jennifer Fostel; Deborah Farlow; David Barbie; Leena Gandhi; Eric S Lander; Stacy W Gray; Steven Joffe; Pasi Janne; Judy Garber; Laura MacConaill; Neal Lindeman; Barrett Rollins; Philip Kantoff; Sheila A Fisher; Stacey Gabriel; Gad Getz; Levi A Garraway
Journal:  Nat Med       Date:  2014-05-18       Impact factor: 53.440
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.